KYMR reports a wider-than-expected loss for the fourth quarter of 2024. The company expects the current cash balance to provide a runway into...

PNW fourth-quarter earnings decrease year over year, while revenues increase. Total operating expenses also rise during the same period.

XENE reports a narrower-than-expected fourth-quarter 2024 loss. Its development programs for azetukalner in epilepsy and MDD are progressing well.

LMND's Q4 2024 results reflect an increase in net earned premiums and an increase in investment income, offset by higher expenses.

SAM's fourth-quarter 2024 results reflect a wider-than-expected loss per share and a sales beat. Depletions remain flat year over year.

Globalstar Q4 revenues beat expectations and increase year over year, driven by growth in service revenues. For 2025, it expects revenues of $260-$285...

Intellia reports better-than-expected fourth-quarter 2024 results. The company provides updates on its pipeline candidates.

AZUL's fourth-quarter bottom line is expected to have been hurt by elevated operating expenses.

ADTN reports top-line growth year over year backed by healthy demand trends across the portfolio in several regions.

AAP reports a narrower-than-expected Q4 loss and expects 2025 net sales from continuing operations in the range of $8.4-$8.6 billion.